Author

H. Tagaya

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Noge· 1 shared K. Semba· 1 shared Y. Doi· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Noge

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMay 26, 2022

Prediction of Resistant Mutations against Upcoming ALK-TKIs, Repotrectinib (TPX-0005) and Ensartinib (X-396)

Y. Doi, H. Tagaya, A. Noge, K. Semba

The paper predicts resistant mutations against new ALK-TKIs, repotrectinib and ensartinib, using an error-prone PCR-based system, suggesting their potential as second-line treatments after alectinib.

DOI 10.1101/2022.05.26.493531

humanexperimental assay

𝕏 PostBluesky